COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS

In one aspect, the present disclosure relates to treating or preventing a respiratory disease or disorder, by administering one or more compositions comprising an isolated polypeptide derived from an alpha Connexin and an anti-viral agent such as, for example, nucleoside analogs. Exemplary respirato...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GREK, Christina L, JAMES, Carissa
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GREK, Christina L
JAMES, Carissa
description In one aspect, the present disclosure relates to treating or preventing a respiratory disease or disorder, by administering one or more compositions comprising an isolated polypeptide derived from an alpha Connexin and an anti-viral agent such as, for example, nucleoside analogs. Exemplary respiratory diseases or disorders include acute respiratory distress syndrome (ARDS), alcoholic lung syndrome, acute lung injury (ALI), pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF), and/or chronic obstructive pulmonary disease (COPD). In some aspects, the respiratory disease or disorder is a complication of a respiratory viral disease. Selon un aspect, la présente divulgation concerne le traitement ou la prévention d'une maladie ou d'un trouble respiratoire, par l'administration d'une ou de plusieurs compositions comprenant un polypeptide isolé dérivé d'une connexine alpha et d'un agent antiviral tel que, par exemple, des analogues de nucléoside. Des exemples de maladies ou de troubles respiratoires comprennent le syndrome de détresse respiratoire aiguë (ARDS), le syndrome pulmonaire alcoolique, une lésion pulmonaire aiguë (ALI), la fibrose pulmonaire, la fibrose pulmonaire idiopathique (IPF) et/ou une maladie pulmonaire obstructive chronique (COPD). Selon certains aspects, la maladie ou le trouble respiratoire est une complication d'une maladie virale respiratoire.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023212446A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023212446A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023212446A13</originalsourceid><addsrcrecordid>eNqNyzELwjAQhuEuDqL-hwNnwabFPSQXG2hz5XJUnEqR6CJaqP8fFQVXp294n2-eXQw1LUUvnkIEHSw0KBXZCI4YhFGLD3t4q9ob_WHkoPOsa_DBofldSSpkYIztqwrxEayPxBY5LrPZebhOafXdRbZ2KKbapPHep2kcTumWHv2B1FYVKldludN58Z96Agw-Nsc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS</title><source>esp@cenet</source><creator>GREK, Christina L ; JAMES, Carissa</creator><creatorcontrib>GREK, Christina L ; JAMES, Carissa</creatorcontrib><description>In one aspect, the present disclosure relates to treating or preventing a respiratory disease or disorder, by administering one or more compositions comprising an isolated polypeptide derived from an alpha Connexin and an anti-viral agent such as, for example, nucleoside analogs. Exemplary respiratory diseases or disorders include acute respiratory distress syndrome (ARDS), alcoholic lung syndrome, acute lung injury (ALI), pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF), and/or chronic obstructive pulmonary disease (COPD). In some aspects, the respiratory disease or disorder is a complication of a respiratory viral disease. Selon un aspect, la présente divulgation concerne le traitement ou la prévention d'une maladie ou d'un trouble respiratoire, par l'administration d'une ou de plusieurs compositions comprenant un polypeptide isolé dérivé d'une connexine alpha et d'un agent antiviral tel que, par exemple, des analogues de nucléoside. Des exemples de maladies ou de troubles respiratoires comprennent le syndrome de détresse respiratoire aiguë (ARDS), le syndrome pulmonaire alcoolique, une lésion pulmonaire aiguë (ALI), la fibrose pulmonaire, la fibrose pulmonaire idiopathique (IPF) et/ou une maladie pulmonaire obstructive chronique (COPD). Selon certains aspects, la maladie ou le trouble respiratoire est une complication d'une maladie virale respiratoire.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231102&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023212446A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231102&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023212446A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GREK, Christina L</creatorcontrib><creatorcontrib>JAMES, Carissa</creatorcontrib><title>COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS</title><description>In one aspect, the present disclosure relates to treating or preventing a respiratory disease or disorder, by administering one or more compositions comprising an isolated polypeptide derived from an alpha Connexin and an anti-viral agent such as, for example, nucleoside analogs. Exemplary respiratory diseases or disorders include acute respiratory distress syndrome (ARDS), alcoholic lung syndrome, acute lung injury (ALI), pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF), and/or chronic obstructive pulmonary disease (COPD). In some aspects, the respiratory disease or disorder is a complication of a respiratory viral disease. Selon un aspect, la présente divulgation concerne le traitement ou la prévention d'une maladie ou d'un trouble respiratoire, par l'administration d'une ou de plusieurs compositions comprenant un polypeptide isolé dérivé d'une connexine alpha et d'un agent antiviral tel que, par exemple, des analogues de nucléoside. Des exemples de maladies ou de troubles respiratoires comprennent le syndrome de détresse respiratoire aiguë (ARDS), le syndrome pulmonaire alcoolique, une lésion pulmonaire aiguë (ALI), la fibrose pulmonaire, la fibrose pulmonaire idiopathique (IPF) et/ou une maladie pulmonaire obstructive chronique (COPD). Selon certains aspects, la maladie ou le trouble respiratoire est une complication d'une maladie virale respiratoire.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyzELwjAQhuEuDqL-hwNnwabFPSQXG2hz5XJUnEqR6CJaqP8fFQVXp294n2-eXQw1LUUvnkIEHSw0KBXZCI4YhFGLD3t4q9ob_WHkoPOsa_DBofldSSpkYIztqwrxEayPxBY5LrPZebhOafXdRbZ2KKbapPHep2kcTumWHv2B1FYVKldludN58Z96Agw-Nsc</recordid><startdate>20231102</startdate><enddate>20231102</enddate><creator>GREK, Christina L</creator><creator>JAMES, Carissa</creator><scope>EVB</scope></search><sort><creationdate>20231102</creationdate><title>COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS</title><author>GREK, Christina L ; JAMES, Carissa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023212446A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GREK, Christina L</creatorcontrib><creatorcontrib>JAMES, Carissa</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GREK, Christina L</au><au>JAMES, Carissa</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS</title><date>2023-11-02</date><risdate>2023</risdate><abstract>In one aspect, the present disclosure relates to treating or preventing a respiratory disease or disorder, by administering one or more compositions comprising an isolated polypeptide derived from an alpha Connexin and an anti-viral agent such as, for example, nucleoside analogs. Exemplary respiratory diseases or disorders include acute respiratory distress syndrome (ARDS), alcoholic lung syndrome, acute lung injury (ALI), pulmonary fibrosis, idiopathic pulmonary fibrosis (IPF), and/or chronic obstructive pulmonary disease (COPD). In some aspects, the respiratory disease or disorder is a complication of a respiratory viral disease. Selon un aspect, la présente divulgation concerne le traitement ou la prévention d'une maladie ou d'un trouble respiratoire, par l'administration d'une ou de plusieurs compositions comprenant un polypeptide isolé dérivé d'une connexine alpha et d'un agent antiviral tel que, par exemple, des analogues de nucléoside. Des exemples de maladies ou de troubles respiratoires comprennent le syndrome de détresse respiratoire aiguë (ARDS), le syndrome pulmonaire alcoolique, une lésion pulmonaire aiguë (ALI), la fibrose pulmonaire, la fibrose pulmonaire idiopathique (IPF) et/ou une maladie pulmonaire obstructive chronique (COPD). Selon certains aspects, la maladie ou le trouble respiratoire est une complication d'une maladie virale respiratoire.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023212446A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A47%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GREK,%20Christina%20L&rft.date=2023-11-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023212446A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true